Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

FDA halts Xencor’s leukaemia drug trial following patient deaths

Immune system T-cells (centre) binding to beads which cause the cells to divide. Credit: Microbe World.

  • FDA puts Xencor’s leukaemia drug trial on hold following patient deaths

Go Top